Urgent safety recall issued for weight-loss medicines in South Africa
The South African Health Products Regulatory Authority (SAHPRA) has issued an urgent recall for specific weight-loss medications. The products affected are known as compounded GLP-1 medicines, which are often used for weight management and blood sugar control.
SAHPRA took this action after identifying severe safety risks associated with these compounded versions of the drugs. Compounded medicines are created by pharmacists to meet the specific needs of an individual patient, but they are not always subject to the same strict testing as mass-produced pharmaceutical products.
Health officials are concerned that these specific versions of the medication may not meet the necessary safety and quality standards required for public use. The regulator has instructed that these products be removed from shelves immediately to protect the health of consumers across the country.
Patients who are currently using GLP-1 medications are advised to check if their medicine is part of the recall. It is recommended that individuals contact their doctor or pharmacist immediately to discuss their treatment plan and find safe, approved alternatives.
This recall serves as a reminder of the importance of using only registered and regulated health products. SAHPRA continues to monitor the situation closely to ensure that all medical products available in South Africa are safe for the public.